Prostate Diagnostic Market Research: Key Insights

Brief:

Market research study for a prostate diagnostic device

Countries:

US

Methodology:

Qualitative and quantitative: urologists, interventional radiologists, and urology oncologists

The research explored:

Working with urologists and oncologists across key markets, we explored current prostate diagnostic pathways — including PSA testing, mpMRI utilisation, targeted and systematic biopsy approaches, and the emerging role of liquid biopsy — to assess workflow integration, clinical decision-making, and the commercial opportunity for a novel prostate diagnostic device.

Delivered:

Detailed analysis of the prostate diagnostic landscape, drivers of current testing and biopsy method selection, attitudinal segmentation of target clinicians, unmet needs across detection, risk stratification, and active surveillance, barriers to adoption of novel diagnostics, and a triangulated market sizing based on prostate cancer incidence, biopsy procedure volumes, and stated physician intent.